Who are in the management team of CRISPR Therapeutics AG?

Jun 22 2025 10:37 PM IST
share
Share Via
As of March 2022, the management team of CRISPR Therapeutics AG includes Dr. Rodger Novak (Chairman, President, Co-Founder) and Dr. Samarth Kulkarni (CEO, Director), along with independent directors Dr. Ali Behbahani, Dr. Bradley Bolzon, Dr. Simeon George, Mr. John Greene, and Dr. Katherine High.
As of March 2022, the management team of CRISPR Therapeutics AG includes the following individuals:

- Dr. Rodger Novak, who serves as the Chairman of the Board, President, and Co-Founder.
- Dr. Samarth Kulkarni, who is the Chief Executive Officer and a Director.

Additionally, the Board of Directors includes several independent directors: Dr. Ali Behbahani, Dr. Bradley Bolzon, Dr. Simeon George, Mr. John Greene, and Dr. Katherine High.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News